Literature DB >> 24821781

Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.

Zahra Sabouri1, Peter Schofield2, Keisuke Horikawa1, Emily Spierings1, David Kipling3, Katrina L Randall1, David Langley2, Brendan Roome2, Rodrigo Vazquez-Lombardi2, Romain Rouet2, Jana Hermes2, Tyani D Chan4, Robert Brink4, Deborah K Dunn-Walters5, Daniel Christ6, Christopher C Goodnow7.   

Abstract

The best-understood mechanisms for achieving antibody self/non-self discrimination discard self-reactive antibodies before they can be tested for binding microbial antigens, potentially creating holes in the repertoire. Here we provide evidence for a complementary mechanism: retaining autoantibodies in the repertoire displayed as low levels of IgM and high IgD on anergic B cells, masking a varying proportion of autoantibody-binding sites with carbohydrates, and removing their self-reactivity by somatic hypermutation and selection in germinal centers (GCs). Analysis of human antibody sequences by deep sequencing of isotype-switched memory B cells or in IgG antibodies elicited against allogeneic RhD+ erythrocytes, vaccinia virus, rotavirus, or tetanus toxoid provides evidence for reactivation of anergic IgM(low) IgD+ IGHV4-34+ B cells and removal of cold agglutinin self-reactivity by hypermutation, often accompanied by mutations that inactivated an N-linked glycosylation sequon in complementarity-determining region 2 (CDR2). In a Hy10 antibody transgenic model where anergic B cells respond to a biophysically defined lysozyme epitope displayed on both foreign and self-antigens, cell transfers revealed that anergic IgM(low) IgD+ B cells form twice as many GC progeny as naïve IgM(hi) IgD+ counterparts. Their GC progeny were rapidly selected for CDR2 mutations that blocked 72% of antigen-binding sites with N-linked glycan, decreased affinity 100-fold, and then cleared the binding sites of blocking glycan. These results provide evidence for a mechanism to acquire self/non-self discrimination by somatic mutation away from self-reactivity, and reveal how varying the efficiency of N-glycosylation provides a mechanism to modulate antibody avidity.

Entities:  

Keywords:  affinity maturation; autoimmunity; clonal selection; self-tolerance

Mesh:

Substances:

Year:  2014        PMID: 24821781      PMCID: PMC4078846          DOI: 10.1073/pnas.1406974111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

1.  Structural evidence for entropic contribution of salt bridge formation to a protein antigen-antibody interaction: the case of hen lysozyme-HyHEL-10 Fv complex.

Authors:  M Shiroishi; A Yokota; K Tsumoto; H Kondo; Y Nishimiya; K Horii; M Matsushima; K Ogasahara; K Yutani; I Kumagai
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

Review 2.  Relative roles of somatic and Darwinian evolution in shaping the antibody response.

Authors:  M Diaz; N R Klinman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis.

Authors:  R Glynne; S Akkaraju; J I Healy; J Rayner; C C Goodnow; D H Mack
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

4.  Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

Authors:  Delin Zhu; Helen McCarthy; Christian H Ottensmeier; Peter Johnson; Terry J Hamblin; Freda K Stevenson
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

5.  Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations.

Authors:  L Linton PJ; D J Decker; N R Klinman
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

Review 6.  Controlling N-linked glycan site occupancy.

Authors:  Jullian Jones; Sharon S Krag; Michael J Betenbaugh
Journal:  Biochim Biophys Acta       Date:  2005-07-25

7.  Light chain somatic mutations change thermodynamics of binding and water coordination in the HyHEL-10 family of antibodies.

Authors:  Mauro Acchione; Claudia A Lipschultz; Morgan E DeSantis; Aranganathan Shanmuganathan; Mi Li; Alexander Wlodawer; Sergey Tarasov; Sandra J Smith-Gill
Journal:  Mol Immunol       Date:  2009-09-24       Impact factor: 4.407

8.  PI3 kinase signals BCR-dependent mature B cell survival.

Authors:  Lakshmi Srinivasan; Yoshiteru Sasaki; Dinis Pedro Calado; Baochun Zhang; Ji Hye Paik; Ronald A DePinho; Jeffrey L Kutok; John F Kearney; Kevin L Otipoby; Klaus Rajewsky
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

9.  B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

Authors:  Tri Giang Phan; Michelle Amesbury; Sandra Gardam; Jeffrey Crosbie; Jhagvaral Hasbold; Philip D Hodgkin; Antony Basten; Robert Brink
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

10.  Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.

Authors:  M P Cooke; A W Heath; K M Shokat; Y Zeng; F D Finkelman; P S Linsley; M Howard; C C Goodnow
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  108 in total

Review 1.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

2.  Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.

Authors:  Corey Tan; James L Mueller; Mark Noviski; John Huizar; Denise Lau; Alexandra Dubinin; Ari Molofsky; Patrick C Wilson; Julie Zikherman
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

Review 3.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

4.  Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice.

Authors:  Yong Chul Kim; Yun Sik Choi; Jehan Alam; Yun-Ji Kim; Keum Jin Baek; Jaemoon Koh; Yeong Wook Song; Doo-Hyun Chung; Youngnim Choi
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 5.  The enigmatic function of IgD: some answers at last.

Authors:  Cindy Gutzeit; Kang Chen; Andrea Cerutti
Journal:  Eur J Immunol       Date:  2018-06-12       Impact factor: 5.532

Review 6.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

7.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

Review 8.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

Review 9.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

10.  Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch.

Authors:  Daniel T MacLeod; Nancy M Choi; Bryan Briney; Fernando Garces; Lorena S Ver; Elise Landais; Ben Murrell; Terri Wrin; William Kilembe; Chi-Hui Liang; Alejandra Ramos; Chaoran B Bian; Lalinda Wickramasinghe; Leopold Kong; Kemal Eren; Chung-Yi Wu; Chi-Huey Wong; Sergei L Kosakovsky Pond; Ian A Wilson; Dennis R Burton; Pascal Poignard
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.